Catalyst Wire Dossier Catalyst Wire Dossier

ABT-450

atazanavir · Abbott Laboratories
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ABT-450, covering 2010-10-13 to 2017-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1 [Phase 1]

See pricing